NEW #WEBINAR ALERT
Uncovering disparities in access to popular treatments: insights from linked EHR and SDOH data - June 26, 1:00pm ET
https://t.co/trOJPCX4hp
Experts from @truveta explore linked #EHR and #SDOH data for #diabetes, #Alzheimersdisease and #heartdisease.
With the #olympics2024 in July, the subject of sports #doping and drug cheats will no doubt become a hot topic again😞.
With that, the PCSIG is proud to announce a new #webinar, moderated by Neil Spooner.
Register: https://t.co/OqsjbIdR0b
WEBINAR: Enabling timely comparative effectiveness research: head-to-head analysis of GLP-1s for weight loss – January 25, 2024 In partnership with @truveta https://t.co/92fWMijWUS
Register for this upcoming webinar on @TheEviBase Base, in association with the PCSIG.
https://t.co/i6qd7Rp2VH
Thank you to our sponsors, Alturas Analytics, Capitainer, @genentech, @TassoInc, Veloxity Labs and @yourbio_health.
Join @aetioninc and @TheEviBase for this new webinar, SURFing the Waters of Real-World Evidence!
Register here: https://t.co/J0gQIuUZig
Join us, November 8 at 11am EST.
#realworldevidence#rwe#realworlddata#FDA
Read highlights from the latest instalment of Sreeram Ramagopalan’s (@LCP_Actuaries) industry news round-up, which discusses some of the latest developments regarding real-world evidence in the context of health technology assessment >>> https://t.co/787o2Jqn0A
#RWE#HTA
New study assesses whether routine #PRO monitoring alone has an impact on real-world overall survival and hospitalizations among individuals diagnosed with lung, breast, or colorectal #cancer >>> https://t.co/LxmEE6wrhv
Our weekly round-up has now been published and includes the @OHENews report on real-world evidence in reimbursement decision making and a new label expansion by the @US_FDA marking a milestone in the regulatory use of RWE for medical devices.
Read here >> https://t.co/5PypyqmzXM
Johnson & Johnson and Astellas add to the growing number of lawsuits filed against the US Inflation Reduction Act’s drug price negotiation provisions https://t.co/0934Sl68Io
Read highlights from the latest instalment of Sreeram Ramagopalan’s industry news round-up, discussing some of the latest developments regarding #RWE in the context of #HTA and is published bi-monthly in our partner journal @Journal_CER >>> https://t.co/Ku0aKiglDW
Study demonstrates an algorithm for selecting statistical models for network meta-analyses where the treatment effect varies over time.
#CER#HEOR#MetaAnalysis
>>> https://t.co/UV6rxghFx8